期刊文献+

中缅边境恶性疟原虫对青蒿素类药体外敏感性检测和K-13基因突变的相关性研究

In vitro susceptibility of Plasmodium falciparumto artemisinin drugs and K13-propeller polymorphisms at the China-Myanmar border
下载PDF
导出
摘要 目的研究中缅边境恶性疟原虫对青蒿素类药物抗药机制。方法收集分离自2008—2010年中缅边境确诊为恶性疟病人体内的疟原虫,共34株,进行体外培养;提取原虫血DNA,采用聚合酶链式反应(PCR)方法,扩增PF3D7-1343700(K-13)基因,对目标基因进行全基因测序,检测K-13基因变异情况;依据基因有无变异分为两组,对比两个组别疟原虫对3种抗疟药青蒿琥酯(Artesunate,AS)、双氢青蒿素(Dihydroartemisinine,DHA)和青蒿素(artemisinin,ART)的半效抑虫浓度(IC50值),并与野生株3D7做对比;随后将这些疟原虫在环状体时期暴露于大剂量的DHA下,6h后洗尽药物,再经过66h培养后涂片,计算生存率(RSA),比较变异株和非变异株之间有无差异。结果检测发现疟原虫K13基因存在137-142位点NN插入(占82.4%),另有E252Q、F446I、C469Y、R539T、P553L、P574L、H719N位点突变,均伴有NN插入,其中F446I(占44.1%)。病人株的IC50值和野生株无统计学差异(P>0.05),但病人株的RSA高于野生株(P<0.05);有K13基因变异组和无变异组对AS、DHA、ART的IC50值无统计学差异(P>0.05),但有基因变异组的RSA高于无基因变异组(P<0.05)。结论本研究结果发现K-13基因变异与恶性疟原虫对青蒿素类药物抗药性可能相关。 This study aims to evaluate drug resistance mechanism to artemisinin derivatives in Plasmodium falciparum.The parasites of patients collected from the China-Myanmar border from 2008 to 2010were cultured in vitro,and DNAs were extracted.The full-length of K13 gene was sequenced in all samples using polymerase chain reaction and direct sequencing methods.To measure drug susceptibilities in artesunate(AS),dihydroartemisinin(DHA)and artemisinin(ART),we calculated the50%inhibitory concentrations(IC50s).Parasites were exposed to high-dose of dihydroartemisinin in ring stage for 6hours,and the survival rates of the ring stage(RSA)was calculated after 66 hours.We found that there were no difference in IC50 s in patient isolates and Standard strain-3D7,and RSA in parasite isolates was significantly higher than 3D7.Sever point mutations(E252Q F446IC469 Y R539T P553 L P574L H719N)were identified in58.8% of the parasite isolates,and F446 Imutation predominated in 44.1% of the parasite isolates.NN-insert mutation predominated in 82.4%,the total point mutations were accompanied by NN-insert.All sample were divided into two groups:gene mutation and no-mutation.We found that there were no difference in IC50 in gene mutation and no-mutation in K-13,and RSA in parasite isolates with K13 mutations was significantly higher than that in wild-type isolates.This result suggest that K13 mutations were possible correlated with artemisinin resistance.
出处 《中国人兽共患病学报》 CAS CSCD 北大核心 2016年第3期219-223,共5页 Chinese Journal of Zoonoses
基金 国家自然科学基金(No.U1202226 81161120421 31260508) 云南省科技厅-昆明医科大学应用基础研究联合专项(No.2015FB034 2014FB005) 昆明医科大学创新基金(2014-D2)联合资助 云南公共卫生与疾病防控协同创新中心项目(No.2014YNPHXT05) 云南省自然科学基金(No.2012FB153)~~
关键词 恶性疟原虫 青蒿素类药物 耐药机制 PF3D7_1343700 Plasmodium falciparum artemisinin derivatives drug resistance PF3D7_1343700
  • 引文网络
  • 相关文献

参考文献11

  • 1Kyaw MP, Nyunt MH, Chit K, et al. Reduced susceptibility of Plasmodium falciparum to artesunate in Southern Myanmar [J]. Plos One, 2013,8(3): e57689. DOI: 10. 1371/journal. Pone. 0057689.
  • 2Denis MB, Tsuyuoka R, Poravuth Y, et al. Surveillance of the efficacy of artesunate and mefloquine combination for the treat- ment of uncomplicated falciparum malaria in Cambodia[J]. Trop Med Int Health, 2006, 11(9): 1360-1366. DOI= 10. llll/j. 1365-3156. 2006. 01690. x.
  • 3Trager W,Jensen JB. Human malaria parasites in continous cul- ture[J]. Science, 1976,193(4254) : 673 675. DOI: 10. 1645/0022- 3395(2005)09110484 : HMPICC]2.0. CO; 2.
  • 4Zui L, Wang Z, Miao J,et al. Mechanisms of in vitro resistance to dihydroartemisinin in Plasmodium falciparum [J]. Mol Mi- :robiol, 2012,86(1): 111-128. DOI=10.1111/j. 1365-2958. 2012. 38180. X.
  • 5Codd A, Teuseher F, Kyle DE, et al. Artemisinin-induced para- site dormancy= a plausible mechanism for treatment failure[J]. VialariaJ, 2011, 10(1): 56. DOI: 10. 1186 / 1475 2875-10-56.
  • 6Shannon TH, Christopher G, Joana C,et al. Independent emer- ;ence of artemisinin resistance mutations amon Plasmodium fal- iparum in southeast asia[J]. J Infect Dis, 2014, 211(5):680- 388. DOh 10. 1093/infdis/jiu491.
  • 7Feng J, Zhou D, Lin Y, et al . Amplification of pfmdrl, pfcrt, pvmdrl and K13 propeller polymorphism associated with Plas- modium falciparum and Plasmodium viva:r at the China-Myan- mar border [J]. Antimicrob Agents Chemother 2015,59 (5) : 2554-2559. DOI : 10.1128/ AAC.04843-14.
  • 8Ashley EA, Dhorda M, Fairhurst RM,et al. Spread of Arternisi- nin resistance in Plasmodium falciparum malaria[J]. N Engl J Med, 2014,371(5) ;1099 1104. DOh 10. 1056/NEJMoa1314981.
  • 9Nyunt MH, Hlaing T, Oo HW,et al. Molecularassessment of artemisinin resistance markers, polymorphisms in the K13propeller and a multidrug-resistance gene, in eastern and western border- areas of Myanmar [J]. Clin Infect Dis, 2015,60(8) 1208-1215. doi: 10. 1093/cid/ciu1160.
  • 10Takala-Harrison S, Jacob CG, Arze C, et al. Independent emergence of artemisinin resistance mutations among Plasrno- dium falciparum in Southeast Asia [J]. J Infect Dis,2015,211 (5) : 670-679. DOI: 10. 1093/infdis/jiu491.

相关主题

;
使用帮助 返回顶部